44 related articles for article (PubMed ID: 38474593)
1. Preparation of Hematoporphyrin-Poly(Lactic Acid) Nanoparticles Encapsulated Perfluoropentane/Salicylic Acid for Enhanced US/CEST MR Bimodal Imaging.
Ding L; Xu F; Luo B; Cheng L; Huang L; Jia Y; Ding J
Int J Nanomedicine; 2024; 19():4589-4605. PubMed ID: 38799695
[TBL] [Abstract][Full Text] [Related]
2. Preparation and Evaluation of Folate Modified PEG-PLLA Nanoparticles Loaded with Lycorine for Glioma Treatment.
Ding J; Su J; Luo B; Ding L
Molecules; 2024 Feb; 29(5):. PubMed ID: 38474593
[TBL] [Abstract][Full Text] [Related]
3. Tumor-targeted paclitaxel-loaded folate conjugated poly(ethylene glycol)-poly(L-lactide) microparticles produced by supercritical fluid technology.
Huang X; Zhang Y; Yin G; Pu X; Liao X; Huang Z; Chen X; Yao Y
J Mater Sci Mater Med; 2015 Feb; 26(2):95. PubMed ID: 25649516
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel molecularly imprinted polymer-PEG-folate nanoparticles for targeting anticancer delivery: Characterization and cellular cytotoxicity.
Esfandyari-Manesh M; Darvishi B; Ishkuh FA; Shahmoradi E; Mohammadi A; Javanbakht M; Dinarvand R; Atyabi F
Mater Sci Eng C Mater Biol Appl; 2016 May; 62():626-33. PubMed ID: 26952466
[TBL] [Abstract][Full Text] [Related]
5. Folate and Pegylated Aliphatic Polyester Nanoparticles for Targeted Anticancer Drug Delivery.
Tsolou A; Angelou E; Didaskalou S; Bikiaris D; Avgoustakis K; Agianian B; Koffa MD
Int J Nanomedicine; 2020; 15():4899-4918. PubMed ID: 32764924
[TBL] [Abstract][Full Text] [Related]
6. Optimization, Characterization and in vivo Evaluation of Paclitaxel-Loaded Folate-Conjugated Superparamagnetic Iron Oxide Nanoparticles.
Gui G; Fan Z; Ning Y; Yuan C; Zhang B; Xu Q
Int J Nanomedicine; 2021; 16():2283-2295. PubMed ID: 33776433
[TBL] [Abstract][Full Text] [Related]
7. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
8. Box-Behnken Design of Experiments of Polycaprolactone Nanoparticles Loaded with Irinotecan Hydrochloride.
Mahmoud BS; McConville C
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111756
[TBL] [Abstract][Full Text] [Related]
9. Receptor biology: Challenges and opportunities.
Mani I; Singh V
Prog Mol Biol Transl Sci; 2023; 196():337-349. PubMed ID: 36813364
[TBL] [Abstract][Full Text] [Related]
10.
Liu J; Sun S; Zhou C; Sun Z; Wang Q; Sun C
J Cancer; 2022; 13(10):3151-3159. PubMed ID: 36046655
[TBL] [Abstract][Full Text] [Related]
11. Development and Optimization of Acriflavine-Loaded Polycaprolactone Nanoparticles Using Box-Behnken Design for Burn Wound Healing Applications.
Nawaz T; Iqbal M; Khan BA; Nawaz A; Hussain T; Hosny KM; Abualsunun WA; Rizg WY
Polymers (Basel); 2021 Dec; 14(1):. PubMed ID: 35012125
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticles for Cancer Therapy: Current Progress and Challenges.
Gavas S; Quazi S; KarpiĆski TM
Nanoscale Res Lett; 2021 Dec; 16(1):173. PubMed ID: 34866166
[TBL] [Abstract][Full Text] [Related]
13. Targeting Cancer Cells Overexpressing Folate Receptors with New Terpolymer-Based Nanocapsules: Toward a Novel Targeted DNA Delivery System for Cancer Therapy.
Bellotti E; Cascone MG; Barbani N; Rossin D; Rastaldo R; Giachino C; Cristallini C
Biomedicines; 2021 Sep; 9(9):. PubMed ID: 34572461
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]